This compound is a derivative of Cyclosporin A featuring a modification at position 6 with (3R,4R)-3-(Acetyloxy)-N,4-dimethyl-6-oxo-L-norleucine. Cyclosporin A derivatives are potent immunosuppressants that inhibit T-cell activation via the calcineurin pathway.

It is utilized in pharmacological research to study prevention of organ transplant rejection, treatment of autoimmune diseases such as rheumatoid arthritis and psoriasis, anti-inflammatory effects in dermatology, and immune modulation in cancer models.

This specialty chemical serves as a research tool for investigating targeted immune therapies with potentially improved selectivity and reduced systemic effects compared to parent Cyclosporin A.